Stanford University
Showing 161-180 of 2,546 Results
-
Max Lamparth
Research Fellow
BioMax is a Research Fellow at the Hoover Institution’s Technology Policy Accelerator and a member of the Stanford Intelligence Systems Laboratory and the Stanford Center for AI Safety at Stanford University.
With his research, he is working towards making AI systems inherently more secure and safe, providing critical insights to inform and guide effective AI policies, and shape public discourse. He specializes in interpretability and robustness of AI systems, ethical decision-making of language models, and uncertainty quantification. His work aims to promote the safe and responsible use of AI in society, with a particular emphasis on language models for automated decision-making, and has been recognized through publications in leading technical and socio-technical conferences such as NeurIPS, CoLM, FAccT, and AIES, as well as policy-oriented outlets like Foreign Affairs. Additionally, his research has garnered attention from international media, with coverage in the MIT Technology Review, The Washington Times, The Japan Times, LaPress, Axios, Deutschlandfunk, and New Scientist.
Prior to his current appointment, he was a postdoctoral fellow at the Stanford Center for AI Safety, the Center for International Security and Cooperation, and the Stanford Existential Risks Initiative at Stanford University advised by Prof. Clark Barrett, Prof. Steve Luby, and Prof. Paul Edwards. Max received his Ph.D. in August 2023 from the School of Natural Sciences at the Technical University of Munich and holds a B.Sc. and M.Sc. in Physics from the Ruprecht Karl University of Heidelberg. -
Johnson Lamwatthananon
Master of Arts Student in East Asian Studies, admitted Winter 2026
Current Research and Scholarly InterestsUS-China-Taiwan Relations
-
Linda (Yu-Ling) Lan
Basic Life Research Scientist, Genetics
BioLinda Lan, DVM, PhD is a postdoctoral fellow in the Snyder Lab. Her research focuses on understanding long-term illness post-acute infections by using a combination of different types of data (multi-omics) and wearable technologies. Currently, Linda is working on three projects.
The first project involves studying the shared mechanisms of long COVID, ME/CFS, and PTLDS using smartwatches and micro-sampling. The second project involves examining the role of autoantibodies in long COVID patients and COVID vaccine side effects. The third project involves exploring the changes in the molecular and physiological responses of astronauts during short space flights using multi-omics and wearable devices.
Linda previously conducted her PhD research at the University of Chicago, where she studied memory B cell responses to a chimeric-based universal influenza virus vaccine candidate. In her leisure time, she enjoys running, hiking, and listening to audiobooks. -
James Landay
Denning Director of Stanford Institute for Human-Centered AI, Anand Rajaraman and Venky Harinarayan Professor and Senior Fellow at the Stanford Institute for Human-Centered AI
Current Research and Scholarly InterestsLanday's current research interests include Technology to Support Behavior Change (especially for health and sustainability), Demonstrational User Interfaces, Mobile & Ubiquitous Computing, Cross-Cultural Interface Design, Human-Centered AI, and User Interface Design Tools. He has developed tools, techniques, and a top professional book on Web Interface Design.
-
Lukas D. Landegger
Clinical Instructor, Otolaryngology (Head and Neck Surgery)
BioDr. Landegger is a fellowship-trained clinician-scientist in otology, neurotology, and lateral skull base surgery and Instructor at Stanford University School of Medicine. After gaining clinical as well as research experience in various countries (US, UK, France, Spain, Germany, Singapore, Australia), he specialized in otology with translational hearing research in Vienna, Austria and for five years in Boston (Mass Eye and Ear, Harvard Medical School), leading to a PhD in Neuroscience. Apart from clinical projects, current basic research foci are funded by a grant obtained from the American Society of Gene & Cell Therapy and include inner ear gene therapy, vestibular schwannoma, noise-induced hearing loss, and others.
